美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=AIR"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
NAFAZAIR 040073 001 ANDA NAPHAZOLINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC 0.1% No No 1994/05/25 1994/05/25 BAUSCH AND LOMB Discontinued
OTICAIR 064065 001 ANDA HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE SUSPENSION/DROPS;OTIC 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML No No 1996/08/28 1996/08/28 BAUSCH AND LOMB Prescription
SINGULAIR 020829 002 NDA MONTELUKAST SODIUM TABLET;ORAL EQ 10MG BASE Yes Yes 1998/02/20 1998/02/20 ORGANON Prescription
SINGULAIR 020830 001 NDA MONTELUKAST SODIUM TABLET, CHEWABLE;ORAL EQ 5MG BASE Yes Yes 1998/02/20 1998/02/20 ORGANON Prescription
SINGULAIR 020830 002 NDA MONTELUKAST SODIUM TABLET, CHEWABLE;ORAL EQ 4MG BASE Yes No 1998/02/20 2000/03/03 ORGANON Prescription
ADVAIR DISKUS 100/50 021077 001 NDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.1MG/INH;EQ 0.05MG BASE/INH Yes Yes 2000/08/24 2000/08/24 GLAXO GRP LTD Prescription
ADVAIR DISKUS 250/50 021077 002 NDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.25MG/INH;EQ 0.05MG BASE/INH Yes Yes 2000/08/24 2000/08/24 GLAXO GRP LTD Prescription
ADVAIR DISKUS 500/50 021077 003 NDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.5MG/INH;EQ 0.05MG BASE/INH Yes Yes 2000/08/24 2000/08/24 GLAXO GRP LTD Prescription
SINGULAIR 021409 001 NDA MONTELUKAST SODIUM GRANULE;ORAL EQ 4MG BASE/PACKET Yes Yes 2002/07/26 2002/07/26 ORGANON Prescription
XOLAIR 103976 001 BLA OMALIZUMAB VIAL 150MG/VIAL No No 2003/06/20 -- GENENTECH Prescription
XOLAIR 103976 002 BLA OMALIZUMAB SYRINGE 75MG/0.5ML No No 2003/06/20 -- GENENTECH Prescription
XOLAIR 103976 003 BLA OMALIZUMAB SYRINGE 150MG/ML No No 2003/06/20 -- GENENTECH Prescription
XOLAIR 103976 004 BLA OMALIZUMAB SYRINGE 300MG/2ML No No 2003/06/20 -- GENENTECH Prescription
PROAIR HFA 021457 001 NDA ALBUTEROL SULFATE AEROSOL, METERED;INHALATION EQ 0.09MG BASE/INH Yes Yes 2004/10/29 2004/10/29 TEVA BRANDED PHARM Prescription
ADVAIR HFA 021254 001 NDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE AEROSOL, METERED;INHALATION 0.045MG/INH;EQ 0.021MG BASE/INH Yes Yes 2006/06/08 2006/06/08 GLAXO GRP LTD Prescription
ADVAIR HFA 021254 002 NDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE AEROSOL, METERED;INHALATION 0.115MG/INH;EQ 0.021MG BASE/INH Yes Yes 2006/06/08 2006/06/08 GLAXO GRP LTD Prescription
ADVAIR HFA 021254 003 NDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE AEROSOL, METERED;INHALATION 0.23MG/INH;EQ 0.021MG BASE/INH Yes Yes 2006/06/08 2006/06/08 GLAXO GRP LTD Prescription
LETAIRIS 022081 001 NDA AMBRISENTAN TABLET;ORAL 5MG Yes No 2007/06/15 2007/06/15 GILEAD Prescription
LETAIRIS 022081 002 NDA AMBRISENTAN TABLET;ORAL 10MG Yes Yes 2007/06/15 2007/06/15 GILEAD Prescription
TUDORZA PRESSAIR 202450 001 NDA ACLIDINIUM BROMIDE POWDER, METERED;INHALATION 0.4MG/INH Yes Yes 2012/07/23 2012/07/23 COVIS Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2026 DrugFuture->U.S. FDA Drugs Database